Medizinische Universit├Ąt Graz - Research portal

Selected Publication:

Singer, CF; Egle, D; Greil, R; Petru, E; Ohler, L; Balic, M; Tinchon, C; Pfeiler, G; Marhold, M; Brunner, C; Haider, K; Galid, A; Pluschnig, U; Haslbauer, F; Hubalek, M; Redl, A; Flatschacher, J; Uthman, S; Mraz, B; Bartsch, R.
REACH AUT: Efficacy and safety of first-line (1L) ribociclib (RIB) plus endocrine therapy (ET) in HR+, HER2-metastatic breast cancer (MBC) from a real-world (RW) study: 3rd interim analysis
ANN ONCOL. 2022; 33: S217-S217. Doi: 10.1016/j.annonc.2022.03.214 [Poster]
Web of Science FullText FullText_MUG

 

Authors Med Uni Graz:
Balic Marija
Petru Edgar
Altmetrics:

Dimensions Citations:
Plum Analytics:


Scite (citation analytics):


© Med Uni GrazImprint